When: Tue, June 16, 2020. 3:00 PM – 4:00 PM EDT [Read more…] about Webinar on Tuesday, June 16th: Harnessing neuroplasticity to transform brain rehabilitation
“A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending FDA submission [Read more…] about Large study finds positive yet mixed results from Akili’s digital therapeutic for kids with ADHD
Brain-wave pattern can identify people likely to respond to antidepressant, study finds (Stanford Medicine press release):
“A new method of interpreting brain activity could potentially be used in clinics to help determine the best treatment options for depression, according to a study led by researchers at the Stanford School of Medicine.
Stanford researchers and their collaborators used electroencephalography, a tool for monitoring electrical activity in the brain, and an algorithm to identify a brain-wave signature in [Read more…] about Machine-learning study finds EEG brain signatures that predict response to antidepressant treatments
Academic difficulties are one of the most important adverse consequences of ADHD, and they frequently contribute to parents’ decision to seek treatment for their child. Whether treatment consistently yields a positive impact on long-term academic success is thus an important issue; however, the answer to this question has been somewhat controversial. [Read more…] about Study finds combined pharma + non-pharma treatment most beneficial to help youth with ADHD address long-term academic difficulties
“A study published online on Friday, October 4, in The American Journal of Psychiatry found that deep brain stimulation (DBS) of an area in the brain called the subcallosal cingulate (SCC) provides a robust antidepressant effect that is sustained over a long period of time in patients with treatment-resistant depression [Read more…] about Persistence pays off: After 8‑year follow-up, study finds robust and sustained antidepressant response to deep brain stimulation (DBS)
“Prescription digital therapeutics company Pear Therapeutics announced late last week that it has filed an FDA marketing authorization for Somryst, its digital cognitive behavioral therapy for the treatment of adults with chronic insomnia and depression.
While an approval from the agency would mark the third authorized prescription digital therapeutic for Pear [Read more…] about Can digital Cognitive Behavioral Therapy (CBTi) become the universal first-line treatment for insomnia?